Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report

Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report Overview  A male patient, 52 years of age, underwent pneumonectomy of the left lung. He was previously diagnosed with primary spindle cell carcinoma (pT4aN1M0, stage III B) with programmed death-ligand 1 expression (tumor proportion score ≥95%) and without epidermal growth factor

Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report